Leadless Pacemaker
Article Sidebar
Main Article Content
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the Royal Thai Army Medical Department and published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.
Use or modification of the articles is prohibited without permission.
Statements expressed in the articles are solely the opinions of the authors.
Authors are fully responsible for the content and accuracy of their articles.
Any other republication of the articles requires permission from the journal.
References
Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728-35.
Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85:774-6, A9.
Cantillon DJ, Exner DV, Badie N, Davis K, Gu NY, Nabutovsky Y, et al. Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide Assessment. JACC Clin Electrophysiol. 2017;3:1296-305.
Cantillon DJ, Dukkipati SR, Ip JH, Exner DV, Niazi IK, Banker RS, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 2018;15:1023-30.
Wang Y, Hou W, Zhou C, Yin Y, Lu S, Liu G, et al. Meta-analysis of the incidence of lead dislodgement with conventional and leadless pacemaker systems. Pacing Clin Electrophysiol. 2018;41:1365-71.
Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med. 2015;373:1125-35.
Knops RE, Tjong FV, Neuzil P, Sperzel J, Miller MA, Petru J, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. 2015;65:1497-504.
Reddy VY, Knops RE, Sperzel J, Miller MA, Petru J, Simon J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129:1466-71.
Lakkireddy D, Knops R, Atwater B, Neuzil P, Ip J, Gonzalez E, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm. 2017;14:1756-63.
Reddy VY, Exner DV, Doshi R, Tomassoni G, Bunch TJ, Estes NAM, et al. Primary Results on Safety and Efficacy From the LEADLESS II-Phase 2 Worldwide Clinical Trial. JACC Clin Electrophysiol. 2022;8:115-7.
Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016;374:533-41.
Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14:702-9.
El-Chami MF, Al-Samadi F, Clementy N, Garweg C, MartinezSande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15:1800-7.
Roberts PR, Clementy N, Al Samadi F, Garweg C, Martinez-Sande JL, Iacopino S, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14:1375-9.
El-Chami MF, Soejima K, Piccini JP, Reynolds D, Ritter P, Okabe T, et al. Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol. 2019;42:1105-10.
El-Chami MF, Bonner M, Holbrook R, Stromberg K, Mayotte J, Molan A, et al. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm. 2020;17:1393-7.
Dar T, Akella K, Murtaza G, Sharma S, Afzal MR, Gopinathannair R, et al. Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience. J Interv Card Electrophysiol. 2020;57:133-40.
Li J, Hou WB, Cao MK, Zhou WX, Wang Y, Fang Y, et al. Safety and efficacy of leadless pacemaker retrieval. J Cardiovasc Electrophysiol. 2019;30:1671-8.
Bhatia NK, Kiani S, Merchant FM, Delurgio DB, Patel AM, Leon AR, et al. Life cycle management of Micra transcatheter pacing system: Data from a high-volume center. J Cardiovasc Electrophysiol. 2021;32:484-90.
Hauser RG, Hayes DL, Kallinen LM, Cannom DS, Epstein AE, Almquist AK, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm. 2007;4:154-60.
Loring Z, North R, Hellkamp AS, Atwater BD, Frazier-Mills CG, Jackson KP, et al. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing Clin Electrophysiol. 2020;43:1461-6.
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427-520.
Hala P, Neuzil P, Keller J, Moucka P, Mudroch M, Dujka L, et al. Quantification of artifacts during cardiac magnetic resonance in patients with leadless Micra pacemakers. J Cardiovasc Electrophysiol. 2021;32:1367-75.
Kiblboeck D, Reiter C, Kammler J, Schmit P, Blessberger H, Kellermair J, et al. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. J Cardiovasc Magn Reson. 2018;20:47.
Kruse I, Arnman K, Conradson TB, Ryden L. A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation. 1982;65:846-55.
Chinitz L, Ritter P, Khelae SK, Iacopino S, Garweg C, GraziaBongiorni M, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies. Heart Rhythm. 2018;15:1363-71.
Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. JACC Clin Electrophysiol. 2020;6:94-106.
Bereuter L, Gysin M, Kueffer T, Kucera M, Niederhauser T, Fuhrer J, et al. Leadless Dual-Chamber Pacing: A Novel Communication Method for Wireless Pacemaker Synchronization. JACC Basic Transl Sci. 2018;3:813-23.
Vatterott PJ, Eggen MD, Hilpisch KE, Drake RA, Grubac V, Anderson TA, et al. Implant, performance, and retrieval of an atrial leadless pacemaker in sheep. Heart Rhythm. 2021;18:288-96.
Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, et al. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med. 2020;383:526-36.
Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, et al. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator. JACC Clin Electrophysiol. 2017;3:1487-98.
Tjong FV, Brouwer TF, Smeding L, Kooiman KM, de Groot JR, Ligon D, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace. 2016;18:1740-7.
Breeman KTN, Swackhamer B, Brisben AJ, Quast ABE, Carter N, Shuros A, et al. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study. Heart Rhythm. 2022;19:837-46.
Fernandez-Palacios G, Garcia-Moran E, Sandin-Fuentes M, GarciaGranja PE, Rubio J, San Roman AJ. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace. 2021;23:814.
Wijesuriya N, Elliott MK, Mehta V, Sidhu BS, Strocchi M, Behar JM, et al. Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions. Front Physiol. 2022;13:898866.
Auricchio A, Delnoy PP, Butter C, Brachmann J, Van Erven L, Spitzer S, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace. 2014;16:681-8.
Reddy VY, Miller MA, Neuzil P, Sogaard P, Butter C, Seifert M, et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study. J Am Coll Cardiol. 2017;69:2119-29.
Sieniewicz BJ, Betts TR, James S, Turley A, Butter C, Seifert M, et al. Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system. Heart Rhythm. 2020;17:1291-7.
Wijesuriya N, Elliott MK, Mehta V, Sidhu BS, Behar JM, Niederer S, et al. Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis. Heart Rhythm. 2022;19:1176-83.
Okabe T, Hummel JD, Bank AJ, Niazi IK, McGrew FA, Kindsvater S, et al. Leadless left ventricular stimulation with WiSE-CRT System - Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase). Heart Rhythm. 2022;19:22-9.
Carabelli A, Jabeur M, Jacon P, Rinaldi CA, Leclercq C, Rovaris G, et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2021;23: 740-7.
Sidhu BS, Gould J, Porter B, Elliott M, Mehta V, Niederer S, et al. Completely Leadless Cardiac Resynchronization Defibrillator System. JACC Clin Electrophysiol. 2020;6:588-9.
Elliott MK, Sidhu BS, Mehta VS, Gould J, Martic D, Rinaldi CA. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems. Heart Rhythm Case Rep. 2021;7:628-32.
Teigeler T, Kolominsky J, Vo C, Shepard RK, Kalahasty G, Kron J, et al. Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience. Heart Rhythm. 2021;18:743-9.
Padala SK, Ellenbogen KA. Left bundle branch pacing is the best approach to physiological pacing. Heart Rhythm O2. 2020;1:59-67.
